Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study.
Okada T, Fushimi C, Matsuki T, Tokashiki K, Takahashi H, Okamoto I, Sato H, Kondo T, Hanyu K, Kishida T, Ito T, Yamashita G, Masubuchi T, Tada Y, Miura K, Omura GO, Yamashita T, Oridate N, Tsukahara K.
Okada T, et al. Among authors: yamashita g, yamashita t.
Anticancer Res. 2023 Jun;43(6):2717-2724. doi: 10.21873/anticanres.16438.
Anticancer Res. 2023.
PMID: 37247908